"Pinnacle Research Group, LLC is a multi-specialty clinical trials organization and conducts Phase I–IV clinical drug and device studies over a broad therapeutic area, with particular interest in early phase development projects."

During the past decade, Pinnacle Research Group LLC conducted 79 clinical trials. In the 10-year time frame, 79 clinical trials started and 49 clinical trials were completed, i.e. on average, 62% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 36 clinical trials were completed. i.e. 97.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pinnacle Research Group LLC" #1 sponsor was "Pfizer" with 7 trials, followed by "AstraZeneca" with 5 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Novartis Pharmaceuticals" with 5 trials sponsored and "Astellas Pharma Global Development, Inc." with 5 trials sponsored. Other sponsors include 88 different institutions and companies that sponsored additional 65 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pinnacle Research Group LLC" #1 collaborator was "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "Medpace, Inc." with 2 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator, "Premier Research Group plc" with 2 trials as a collaborator and "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Pinnacle Research Group LLC" are "Rheumatoid Arthritis" (20 trials), "Systemic Lupus Erythematosus" (9 trials), "Lupus Erythematosus, Systemic" (6 trials), "Atopic Dermatitis" (5 trials) and "COPD" (3 trials). Many other conditions were trialed in "Pinnacle Research Group LLC" in a lesser frequency.

Most popular intervention types in "Pinnacle Research Group LLC" are "Drug" (108 trials), "Biological" (12 trials), "Other" (11 trials), "Device" (2 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (56 trials), "AC2993" (4 trials), "Methotrexate" (4 trials), "ASN002" (3 trials) and "BI 695501" (3 trials). Other intervention names were less common.

The vast majority of trials in "Pinnacle Research Group LLC" are 117 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Pinnacle Research Group LLC". 1 are not yet recruiting, 11 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 84 completed trials in Pinnacle Research Group LLC, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Pinnacle Research Group LLC, 32 "Phase 1" clinical trials were conducted, 42 "Phase 2" clinical trials and 44 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".